Alkaloid δ agonist BW373U86 increases hypoxic tolerance

Anesthesia and Analgesia

Volumn 82, Issue 6, 1996, Pages 1237-1241

  Bofetiado, Daphne M ^a   Mayfield, Kimberly P ^a   D'Alecy, Louis G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; ALKALOID; BENZYLIDENE DERIVATIVE; BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NORBINALTORPHIMINE; OPIATE AGONIST;

ANIMAL EXPERIMENT; APNEA; ARTICLE; BRAIN INJURY; BRAIN PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DROWNING; DRUG MECHANISM; HEAD INJURY; HYPOXIA; INTRAVENOUS DRUG ADMINISTRATION; LABOR COMPLICATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION;

ACUTE DISEASE; ANIMALS; ANOXIA; BENZAMIDES; BODY TEMPERATURE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED STRAINS; NALTREXONE; NARCOTIC ANTAGONISTS; PIPERAZINES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0029887199     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199606000-00023     Document Type: Article

References (19)

1. Fitch SJ, Gerald B, Magill HL, Tonkin ILD. Central nervous system hypoxia in children due to near drowning. Radiology 1985;156:647-50.
2. Levine JE, Becker D, Chun T. Reversal of incipient brain death from head-injury apnea at the scene of accidents. N Engl J Med 1979;301:109.
3. Brann AW Jr, Dykes FD. The effects of intrautering asphyxia on the full-term neonate. Clin Perinatol 1977;4:149-61.
4. Mayfield KP, D'Alecy LG. Delta-1 opioid agonist acutely increases hypoxic tolerance. J Pharmacol Exp Ther 1994;268:683-8.
5. Rising CL, D'Alecy LG. Hypoxia-induced increases in hypoxic tolerance augmented by β-hydroxybutyrate in mice. Stroke 1989;20:1219-25.
6. Mayfield KP, D'Alecy LG. Delta-1 dependence of acute hypoxic adaptation. J Pharmacol Exp Ther 1994;268:74-7.
7. Chang K-J, Rigdon GC, Howard JL, McNutt RW. A novel, potent and selective nonpeptidic delta opioid agonist BW373U86. J Pharmacol Exp Ther 1993;267:852-6.
8. Ward SJ, Portoghese PS, Takemori AE. Pharmacological characterization in vivo of the novel opiate, β-funaltrexamine. J Pharmacol Exp Ther 1982;220:494-8.
9. Holmes BB, Fujimoto JM. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17). J Pharmacol Exp Ther 1992;261:146-53.
10. 1 opioid receptor antagonist in the mouse spinal cord. Life Sci 1993;52:769-75.
11. Sofuoglu M, Portoghese PS, Takemori AE. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J Pharmacol Exp Ther 1991;257:676-80.
12. Benedetti J, Yuen K, Young L. Life tables and survivor functions. In: Dixon WJ, Brown MB, Engelman L, Jennrich RI, eds. BMDP statistical software manual. Berkeley: University of California Press, 1990.
13. Portoghese PS, Sultana M, Nagase H, Takemori AE. A highly selective δ1-opioid receptor antagonist: 7-benzylidenenaltrexone. Eur J Pharmacol 1992;218:195-6.
14. Takemori AE, Larson DL, Portoghese PS. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur J Pharmacol 1981;70:445-51.
15. Portoghese PS, Lipkowski AW, Takemori AE. Binaltorphimine and norbinaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci 1987;40:1287-92.
16. Wild KD, McCormick J, Bilsky EJ, et al. Antinociceptive actions of BW373U86 in the mouse. J Pharmacol Exp Ther 1993;267:858-65.
17. Mayfield KP, D'Alecy LG. Role of endogenous opioid peptides in the acute adaptation to hypoxia. Brain Res 1992;582:226-31.
18. Spencer RL, Hruby VJ, Burks TF. Alteration of thermoregulatory set point with opioid agonists. J Pharmacol Exp Ther 1990;252:696-705.
19. Comer SD, Hoenicke EM, Sable AI, et al. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J Pharmacol Exp Ther 1993;267:888-95.